Breakfast Symposium - Product Theater - Improving cervical cancer screening: Use of HPV DNA testing to enhance screening effectiveness
18th Annual NPWH Premier Women's Healthcare Conference
In 2012 new guidelines for cervical cancer were released by three major groups: ACOG, the USPSTF and the ACS/ASCCP/ASCP Consensus Conference. In 2014 the FDA approved first-line primary screening testing
for ages 25-29 and in 2015 SGO/ASCCP issued interim guidance. With the evolution of screening methods, it is important to understand the changes in guidelines and management. Discussion will include screening age, how often to screen, and management of results.